MAURICIO A REINOSO

Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease SUGAR LAND, TX NPI 1972597474

General Payments — all program years on this page

$36,407.83

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 268
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $329.43 across 16 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $318.5715
Education $10.861

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $14,998.6364
2019 $12,235.6171
2020 $6,283.7934
2021 $448.4631
2022 $783.2328
2023 $1,328.6824
2024 $329.4316

Records — PY2024 (16)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1104280767 AstraZeneca Pharmaceuticals LP $14.38 11/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104494152 AstraZeneca Pharmaceuticals LP $19.50 06/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104645905 AstraZeneca Pharmaceuticals LP $20.94 09/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104682311 AstraZeneca Pharmaceuticals LP $24.46 10/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105384473 AstraZeneca Pharmaceuticals LP $15.68 08/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105451377 AstraZeneca Pharmaceuticals LP $15.51 08/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105770804 AstraZeneca Pharmaceuticals LP $10.86 10/25/2024 Education Undisputed 01/23/2026 View at CMS
1105864330 AstraZeneca Pharmaceuticals LP $25.62 01/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108480883 Olympus America Inc. $33.80 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116447130 GlaxoSmithKline, LLC. $15.35 09/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118257470 Boehringer Ingelheim Pharmaceuticals, Inc. $35.82 11/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137661310 Takeda Pharmaceuticals U.S.A., Inc. $15.94 03/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137661312 Takeda Pharmaceuticals U.S.A., Inc. $17.82 06/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137661314 Takeda Pharmaceuticals U.S.A., Inc. $17.21 10/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144605236 Xeris Pharmaceuticals, Inc. $16.36 01/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148100717 Inspire Medical Systems, Inc. $30.18 02/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.